Polyphenols as Potential Metal Chelation Compounds against Alzheimer's Disease

Johant Lakey-Beitia, Andrea M. Burillo, Giovanni La Penna, Muralidhar L. Hegde, K. S. Rao

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disease affecting more than 50 million people worldwide. The pathology of this multifactorial disease is primarily characterized by the formation of amyloid-β (Aβ) aggregates; however, other etiological factors including metal dyshomeostasis, specifically copper (Cu), zinc (Zn), and iron (Fe), play critical role in disease progression. Because these transition metal ions are important for cellular function, their imbalance can cause oxidative stress that leads to cellular death and eventual cognitive decay. Importantly, these transition metal ions can interact with the amyloid-β protein precursor (AβPP) and Aβ42 peptide, affecting Aβ aggregation and increasing its neurotoxicity. Considering how metal dyshomeostasis may substantially contribute to AD, this review discusses polyphenols and the underlying chemical principles that may enable them to act as natural chelators. Furthermore, polyphenols have various therapeutic effects, including antioxidant activity, metal chelation, mitochondrial function, and anti-amyloidogenic activity. These combined therapeutic effects of polyphenols make them strong candidates for a moderate chelation-based therapy for AD.

Original languageEnglish (US)
Pages (from-to)S335-S357
JournalJournal of Alzheimer's Disease
Volume82
Issue numbers1
DOIs
StatePublished - 2021

Keywords

  • Alzheimer's disease
  • amyloid-β
  • copper
  • iron
  • metal chelation therapy
  • metalloproteins
  • polyphenols
  • zinc

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Polyphenols as Potential Metal Chelation Compounds against Alzheimer's Disease'. Together they form a unique fingerprint.

Cite this